These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
422 related items for PubMed ID: 19133282
1. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines. Ho TF, Peng YT, Chuang SM, Lin SC, Feng BL, Lu CH, Yu WJ, Chang JS, Chang CC. Toxicol Appl Pharmacol; 2009 Mar 01; 235(2):253-60. PubMed ID: 19133282 [Abstract] [Full Text] [Related]
2. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH. Cancer Res; 2006 May 01; 66(9):4952-60. PubMed ID: 16651453 [Abstract] [Full Text] [Related]
3. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells. Pratt MA, Niu MY, Renart LI. Apoptosis; 2006 Apr 01; 11(4):589-605. PubMed ID: 16528475 [Abstract] [Full Text] [Related]
4. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ. Breast Cancer Res Treat; 2009 Sep 01; 117(1):45-54. PubMed ID: 18791823 [Abstract] [Full Text] [Related]
5. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. Brenes O, Arce F, Gätjens-Boniche O, Díaz C. Biomed Pharmacother; 2007 Jul 01; 61(6):347-55. PubMed ID: 17399942 [Abstract] [Full Text] [Related]
7. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo. Zhang M, Mukherjee N, Bermudez RS, Latham DE, Delaney MA, Zietman AL, Shipley WU, Chakravarti A. Prostate; 2005 Aug 01; 64(3):293-302. PubMed ID: 15754318 [Abstract] [Full Text] [Related]
8. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells. McGuire KP, Ngoubilly N, Neavyn M, Lanza-Jacoby S. J Surg Res; 2006 May 15; 132(2):208-13. PubMed ID: 16580691 [Abstract] [Full Text] [Related]
9. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels. Lu M, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL. Clin Cancer Res; 2008 May 15; 14(10):3168-76. PubMed ID: 18483385 [Abstract] [Full Text] [Related]
10. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin. Jin HO, Yoon SI, Seo SK, Lee HC, Woo SH, Yoo DH, Lee SJ, Choe TB, An S, Kwon TJ, Kim JI, Park MJ, Hong SI, Park IC, Rhee CH. Biochem Pharmacol; 2006 Nov 15; 72(10):1228-36. PubMed ID: 16950207 [Abstract] [Full Text] [Related]
12. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Mittal A, Pate MS, Wylie RC, Tollefsbol TO, Katiyar SK. Int J Oncol; 2004 Mar 15; 24(3):703-10. PubMed ID: 14767556 [Abstract] [Full Text] [Related]
14. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis. Tang C, Lu YH, Xie JH, Wang F, Zou JN, Yang JS, Xing YY, Xi T. Anticancer Drugs; 2009 Apr 15; 20(4):249-58. PubMed ID: 19174695 [Abstract] [Full Text] [Related]
15. Anticancer effects on TACC3 by treatment of paclitaxel in HPV-18 positive cervical carcinoma cells. Yim EK, Tong SY, Ho EM, Bae JH, Um SJ, Park JS. Oncol Rep; 2009 Feb 15; 21(2):549-57. PubMed ID: 19148534 [Abstract] [Full Text] [Related]
16. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ. Breast Cancer Res Treat; 2009 Feb 15; 113(3):443-56. PubMed ID: 18327707 [Abstract] [Full Text] [Related]
17. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells. Kami K, Doi R, Koizumi M, Toyoda E, Mori T, Ito D, Kawaguchi Y, Fujimoto K, Wada M, Miyatake S, Imamura M. Surgery; 2005 Aug 15; 138(2):299-305. PubMed ID: 16153440 [Abstract] [Full Text] [Related]
18. Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells. Reshkin SJ, Bellizzi A, Cardone RA, Tommasino M, Casavola V, Paradiso A. Clin Cancer Res; 2003 Jun 15; 9(6):2366-73. PubMed ID: 12796407 [Abstract] [Full Text] [Related]
19. Contribution of reactive oxygen species and caspase-3 to apoptosis and attenuated ICAM-1 expression by paclitaxel-treated MDA-MB-435 breast carcinoma cells. Fawcett H, Mader JS, Robichaud M, Giacomantonio C, Hoskin DW. Int J Oncol; 2005 Dec 15; 27(6):1717-26. PubMed ID: 16273228 [Abstract] [Full Text] [Related]
20. Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin. Pizzoferrato E, Liu Y, Gambotto A, Armstrong MJ, Stang MT, Gooding WE, Alber SM, Shand SH, Watkins SC, Storkus WJ, Yim JH. Cancer Res; 2004 Nov 15; 64(22):8381-8. PubMed ID: 15548708 [Abstract] [Full Text] [Related] Page: [Next] [New Search]